These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Ph1 chromosome in chronic myeloid leukemia. Its diagnostic and prognostic value]. de Vinuesa ML; de Salum SB Medicina (B Aires); 1981; 41(3):293-6. PubMed ID: 6948147 [No Abstract] [Full Text] [Related]
6. [Cytogenetic evidence of the splenic origin of chronic myeloid leukemia]. Armenta D; Cadotte M; Beaulieu R; Neemeh J; Long L; Pretty H; Gosselin G Union Med Can; 1976 Jun; 105(6):922-7. PubMed ID: 1070891 [No Abstract] [Full Text] [Related]
7. [Contribution of cytogenetics in the study of hemopathies]. Cadotte M Union Med Can; 1979 May; 108(5):511-4. PubMed ID: 293076 [No Abstract] [Full Text] [Related]
8. [Cytogenetics and hemopathies]. Berger R Nouv Rev Fr Hematol; 1972; 12(4):510-5. PubMed ID: 4264208 [No Abstract] [Full Text] [Related]
9. [Significance of cytogenetic methods in the diagnosis and differential diagnosis of myeloproliferative diseases (review of the literature and personal data)]. Fleĭshman EV; Volkova MA Probl Gematol Pereliv Krovi; 1970 Aug; 15(8):53-8. PubMed ID: 4935743 [No Abstract] [Full Text] [Related]
10. [A case of myeloproliferative disorder presenting as chronic neutrophilic leukemia with detection of Ph1 chromosome in long-term culture]. Sanada I; Yamamoto S; Ogata M; Kawakita M; Kawano F; Takatsuki K; Fujiwara H; Tanaka R; Kumagai E Rinsho Ketsueki; 1985 Mar; 26(3):429-35. PubMed ID: 3861890 [No Abstract] [Full Text] [Related]
11. Chromosomal abnormalities in leukemia. Cork A Am J Med Technol; 1983 Oct; 49(10):703-14. PubMed ID: 6359878 [TBL] [Abstract][Full Text] [Related]
12. [Chromosome changes in leukemia]. van der Hagen CB Tidsskr Nor Laegeforen; 1974 Nov; 94(32):2208-9. PubMed ID: 4531114 [No Abstract] [Full Text] [Related]
14. [Cytogenetic studies on chronic myelocytic leukemia. Evolution of clones with additional Ph1 chromosome detected by a large number of karyotype analysis]. Tanaka K; Kamada N; Oguma N; Takimoto Y; Kuramoto A; Ohkita T Rinsho Ketsueki; 1984 Nov; 25(11):1778-87. PubMed ID: 6598207 [No Abstract] [Full Text] [Related]
15. [Chronic myeloid leukemia in children]. Ortega JJ; Javier G; Mayol L Sangre (Barc); 1984; 29(4-B):607-28. PubMed ID: 6393385 [No Abstract] [Full Text] [Related]
16. Hypereosinophilic syndrome with evolution to myeloproliferative disorder: temporal relationship to loss of Y chromosome and c-N-ras activation. Needleman SW; Mane SM; Gutheil JC; Kapil V; Heyman MR; Testa JR Hematol Pathol; 1990; 4(3):149-55. PubMed ID: 2258361 [TBL] [Abstract][Full Text] [Related]
17. [Ph1 and C group marker in a acute leukemia associated with noramidopyrine treatment (author's transl)]. Moraine C; Brémond JL; Despert F; Leroy J; Leroux ME; Maillet M Nouv Rev Fr Hematol; 1974; 14(4):461-70. PubMed ID: 4280556 [No Abstract] [Full Text] [Related]
18. Diagnostic and prognostic value of chromosome studies in cancer. Nowell PC Ann Clin Lab Sci; 1974; 4(4):234-40. PubMed ID: 4533399 [TBL] [Abstract][Full Text] [Related]
20. [Review of the literature and personal experiences in cytogenetic studies in chronic myeloid leukemia]. Brieux de Salum S; Labal de Vinuesa M Medicina (B Aires); 1981; 41 Suppl():170-8. PubMed ID: 7047980 [No Abstract] [Full Text] [Related] [Next] [New Search]